Abiopharma

New Form ARS - Modular Medical, Inc. Filed: 2026-01-08 AccNo: 0001213900-26-002333 Size: 731 KB

New Form DEF 14A - Modular Medical, Inc. Filed: 2026-01-08 AccNo: 0001213900-26-002332 Size: 22 MB

GH Research PLC (GHRS) Files Form 6-K

Trevi Therapeutics Provides Strategic Updates Ahead of Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference

Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11

Plus Therapeutics Announces Read Out of Type B Meeting with the FDA with Goal of Accelerating Approval of REYOBIQ™ for Leptomeningeal Metastases

Vera Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology

(85% Positive) ENTRADA THERAPEUTICS, INC. (TRDA) Announces Clinical Development Update

Indivior Notification

(90% Positive) CULLINAN THERAPEUTICS, INC. (CGEM) Announces Enrollment Update for dosing Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(90% Positive) Opus Genetics, Inc. (OCUP) Announces Enrollment Update for qualify Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(80% Positive) Invivyd, Inc. (IVVD) Announces Enrollment Update for preparing Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(10% Negative) Standard BioTools Inc. (LAB) Announces Business Combination